Loftus, Tia
Loftus, Tia was paid $21K by Medicaid between Dec 2019 and Feb 2023, across 15 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 20% of everything it billed.
GLENVIEW, IL 60026
Next to other Nurse Practitioner providers in Illinois
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 26 | $914.40 | |
| 2020 | 118 | $2K | |
| 2022 | 73 | $3K | |
| 2023 | 386 | $15K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 20% | 56 | 38 | $4K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 99 | 94 | $4K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 12% | 56 | 54 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.8% | 67 | 66 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6.9% | 41 | 39 | $1K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.7% | 35 | 35 | $1K |
| 87428 | 6.1% | 20 | 20 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 5.0% | 42 | 40 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.6% | 31 | 31 | $970.30 |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.3% | 30 | 29 | $901.60 |
| 99349 | 2.3% | 13 | 12 | $475.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 30 | 29 | $471.00 |
3 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.